Hyperion Defi (HYPD) Cash from Investing Activities (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Cash from Investing Activities of -$1.5 million for Q1 2026, up 76.69% quarter-over-quarter from -$6.3 million in Q4 2025.
Hyperion Defi (HYPD) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Cash from Investing Activities for 10 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$27.9 million (changed N/A YoY), while the FY2025 annual figure was -$72.0 million, down 44459.93% from the prior year.
- Cash from Investing Activities advanced to -$1.5 million in Q1 2026 per HYPD's latest filing, from -$6.3 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1.0 in Q4 2024 and bottomed at -$20.1 million in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$2.2 million across 5 years, with a median of -$207662.0 in 2022.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 100.0% — and 2025, when it sank 631903800.0%.
- Hyperion Defi's Cash from Investing Activities stood at -$311786.0 in 2022, then soared by 53.42% to -$145231.0 in 2023, then jumped by 100.0% to -$1.0 in 2024, then tumbled by 631903800.0% to -$6.3 million in 2025, then jumped by 76.69% to -$1.5 million in 2026.
- Business Quant data shows HYPD's Cash from Investing Activities at -$1.5 million in Q1 2026, -$6.3 million in Q4 2025, and -$20.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | -5.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.48 Mn |
| Jun 30, 2026 | -5.48 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Dec 31, 2025 | -6.32 Mn |
| Dec 31, 2025 | -6.32 Mn |
| Sep 30, 2025 | -20.11 Mn |
| Sep 30, 2025 | -20.11 Mn |
| Dec 31, 2024 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | -1,623.00 |
| Sep 30, 2024 | -1,623.00 |
| Jun 30, 2024 | -45,748.00 |
| Jun 30, 2024 | -45,748.00 |
| Mar 31, 2024 | -114,105.00 |
| Mar 31, 2024 | -114,105.00 |
| Dec 31, 2023 | -145,231.00 |
| Dec 31, 2023 | -145,231.00 |
| Sep 30, 2023 | -1.70 Mn |
| Sep 30, 2023 | -1.70 Mn |